期刊论文详细信息
BMC Psychiatry
Tackling the global problem of traumatic stress in low-income countries: a pilot clinical trial comparing reconsolidation therapy to paroxetine in Nepal
Bhushan Guragain1  Laurence J. Kirmayer2  Jacques Tremblay3  Daniel Saumier3  Alain Brunet3  Ram P. Sapkota4 
[1] Centre for Victims of Torture (CVICT), Kathmandu, Nepal;Division of Social and Transcultural Psychiatry, Global Mental Health Program, McGill University, Montréal, QC, Canada;Culture and Mental Health Research Unit, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada;Research Centre of the Douglas Mental Health University Institute, and Department of Psychiatry, McGill University, 6875 boulevard LaSalle, H4H 1R3, Montréal, Quebec, Canada;Research Centre of the Douglas Mental Health University Institute, and Department of Psychiatry, McGill University, 6875 boulevard LaSalle, H4H 1R3, Montréal, Quebec, Canada;Division of Social and Transcultural Psychiatry, Global Mental Health Program, McGill University, Montréal, QC, Canada;
关键词: Traumatic stress;    Paroxetine;    Reconslidation therapy;    Low– and middle–income countries;    Effectiveness;    Efficiency;    Propranolol;    Treatment;    Randomized controlled trial;   
DOI  :  10.1186/s12888-021-03441-6
来源: Springer
PDF
【 摘 要 】

BackgroundTraumatic stress is a global mental health problem requiring novel, easily implemented treatment solutions. We compared the effectiveness and efficiency of Reconsolidation Therapy (RT) to the well-established antidepressant paroxetine, in reducing symptoms of traumatic stress among patients from Nepal, a low-income country.MethodsForty-six adults with posttraumatic stress disorder (PTSD) were randomized to one of two groups. The reconsolidation blocker propranolol was administered 90 min before briefly recalling a traumatic memory with a therapist, weekly for six consecutive weeks. This was compared to daily paroxetine for 26 weeks. Self-reported PTSD symptoms were assessed blindly at the 7th, 13th, and 26th weeks.ResultsAn intent-to-treat analysis revealed a robust pre- to post-treatment main effect (β1 = − 4.83, 95% CI = [− 5.66, − 4.01], p < .001), whereby both groups improved, with Cohen’s effect sizes of d = 2.34 (95% CI = [1.57, 3.12]) for paroxetine, and of 2.82 (95% CI = [1.98, 3.66]) for RT after 7 weeks, suggesting treatment effectiveness for both groups in a real-world setting. Three and six-month follow-up yielded further significant improvement in both groups, which did not differ from each other.ConclusionRT also displayed promising efficiency, considering that it had been discontinued weeks earlier while the paroxetine treatment was continued, as recommended. RT could be taught in low-income countries as part of the local therapeutic resources to treat the core symptoms of PTSD, provided that such results are replicated on a broader scale.Trial registrationISRCTN34308454 (11/10/2017).

【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO202110145101618ZK.pdf 996KB PDF download
  文献评价指标  
  下载次数:35次 浏览次数:22次